Related Experiment Video
Updated: Jul 11, 2026
06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 25, 2010
A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam
P O Maitre1, M Bührer, D Thomson
1Department of Anesthesiology and Intensive Care, University of Bern, Inselspital, Switzerland.
Journal of Pharmacokinetics and Biopharmaceutics
|August 1, 1991
Summary
A new three-step method allows researchers to identify how demographic factors like age and weight affect drug pharmacokinetics. This approach overcomes limitations in standard population pharmacokinetic analysis, enabling better understanding of drug behavior in individuals.
Area of Science:
- Pharmacokinetics
- Population pharmacokinetic analysis
- Drug metabolism
Background:
- Standard population pharmacokinetic analysis using NONMEM lacks individual subject parameter estimates.
- This limitation hinders the investigation of relationships between pharmacokinetic parameters and demographic factors.
- Existing methods do not allow for direct correlation of individual drug parameters with patient characteristics.
Purpose of the Study:
- To develop and validate a novel three-step approach to identify demographic influences on pharmacokinetic parameters.
- To overcome the limitations of NONMEM in providing individual subject parameter estimates for correlation analyses.
- To enable the exploration of relationships between pharmacokinetic parameters and demographic variables such as age, gender, and body weight.
Main Methods:
- A three-step approach was devised: 1. Initial NONMEM analysis for population parameters. 2. Individual Bayesian regressions to estimate subject-specific parameters. 3. Stepwise incorporation of significant demographic factors back into the NONMEM model.
- The method was applied to midazolam pharmacokinetics in 64 subjects, using 714 plasma concentrations and 11 demographic factors.
- Pharmacokinetic parameters were plotted against demographic factors to identify significant correlations.
Main Results:
- Elimination clearance (CL) and V1 were found to be significantly influenced by body weight.
- Age and liver disease were identified as factors that decrease CL.
- None of the 11 demographic factors evaluated were found to influence VSS or intercompartmental clearance.
Conclusions:
- The developed three-step method effectively identifies demographic factors influencing pharmacokinetic parameters.
- Body weight, age, and liver disease are key factors affecting midazolam elimination clearance and volume of distribution.
- This approach enhances the understanding of inter-individual variability in drug pharmacokinetics.
More Related Videos
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
01:29Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...